Skip to main content

Abstract

Radiopharmaceuticals containing complex functional groups are playing an increasing role in diagnostic nuclear medicine due to new developments in the instrumentation used for single-photon emission computerized tomography (SPECT)1 and positron emission tomography (PET).2 These computerized systems permit noninvasive, in vivo, three-dimensional imaging of organs after administration of appropriate agents labeled with short-lived nuclides.3 The techniques are used for in vivo pharmacokinetics, organ imaging, evaluation of organ function, and physiological mapping. They complement the traditional X-ray scan and are’partially responsible for the tremendous upsurge in the use of radiopharmaceuticals in hospitals today.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D. F. Wong and M. J. Kuhar, In vivo PET and SPECT receptor imaging: New technology and tactics for receptor measurement, Adv. Exp. Med. Biol. 236:181 (1988).

    Article  PubMed  CAS  Google Scholar 

  2. M. E. Phelps, J. C. Maziotta, and H. R. Schelbert “Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart”, Raven Press, New York (1986).

    Google Scholar 

  3. P. R. Jolles, P. R. Chapman, and A. Alavi, PET, CT, and MRI in the evaluation of neuro psychiatric disorders: Current applications, J. Nucl. Med. 30: 1589 (1989).

    PubMed  CAS  Google Scholar 

  4. A. Murray, and D. L. Williams, “Organic Synthesis with Isotopes”, Interscience, New York (1958).

    Google Scholar 

  5. J. S. Fowler, and A. P. Wolf, The Synthesis of carbon 11, fluorine-18, and nitrogen-13 labeled radiotracers for biomedical application“, in ”Nuclear Science Series“, Publication NAS-NS-3201, Springfield, VA, National Technical Information Service (1982).

    Google Scholar 

  6. T. J. Tewson, M. J. Welch, and A. P. Wolf, Terminology concerning specific activity of radiopharmaceuticals, J. Nucl. Med. 22: 392 (1981).

    Google Scholar 

  7. G. W. Kabalka, Radionuclide incorporation via organoboranes, in “Aspects of mechanism and organometallic chemistry”, J. H. Brewster, Ed., Plenum Press, New York, 1978.

    Google Scholar 

  8. V. F. Raaen, “Carbon-14”, McGraw-Hill, New York (1968).

    Google Scholar 

  9. A. Pelter, K. Smith, and H. C. Brown, “Borane Reagents”, Academic Press, New York (1988).

    Google Scholar 

  10. G. W. Kabalka, Synthesis of Isotopically Labeled Compounds Via Boranes, in “Boron Chemistry”, S. Hermanek, Ed., World Scientific, New Jersey, (1987).

    Google Scholar 

  11. G. W. Kabalka, Incorporation of stable and radioactive isotopes via organoborane chemistry, Acc. Chem. Res. 17: 215 (1984).

    Article  CAS  Google Scholar 

  12. N. H. Nam, A. J. Russo, and R. F. Nystrom, Preparation of labelled olefins by tritioboration procedures, Chem. Ind. London 1876 (1963).

    Google Scholar 

  13. H. C. Brown “Organic Synthesis Via Boranes”, Wiley Interscience, New York (1975).

    Google Scholar 

  14. N. D. Heindel, H. D. Burns, T. Honda, and L. W. Brady, “The Chemistry of Radiopharmaceuticals”, Masson, New York (1978).

    Google Scholar 

  15. W. G. Myers, Radioiodine, in “Radioactive Pharmaceuticals”, USAEC Symp. Conf. 651111, Springfield VA, National Bureau of Standards, Washington, D. C., 217 (1966).

    Google Scholar 

  16. T. C. Hill, B. L. Holman, R. Lovett, D. H. O’Leary, D. Front, P. Magistretti, R. E. Zimmerman, S. Moore, M. E. Clouse, J. L. Wu, T. H. Lin, and R. M. Baldwin, Initial experience with spect of the brain using n-isopropyl I-123 p-iodoamphetamine: Concise communication, J.Nucl. Med. 23: 191, (1982).

    PubMed  CAS  Google Scholar 

  17. A. Hock, C. Freundlib, K. Vyska, B. Losse, R. Erbel, and L. E. Feinendegen Myocardial Imaging and Metabolic Studies with [17-f23I]iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy, J. Nucl. Med. 24: 22 (1983).

    PubMed  CAS  Google Scholar 

  18. M. Nakajo, B. Shapiro J. Copp, V. Kalffe, M. D. Gross, J. C. Sisson, and W. H. Beierwaltes, The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]-123 iodobenzylguanidine (I-131 M1BG) in man, J. Nucl. Med. 24: 672 (1983).

    PubMed  CAS  Google Scholar 

  19. G. W. Kabalka and E. E. Gooch, A mild convenient procedure for the conversion of alkenes into alkyl iodides via the reaction of iodine monochloride with organo-boranes, J. Org. Chem. 45: 3578 (1980).

    Article  CAS  Google Scholar 

  20. G. W. Kabalka and E. E. Gooch, A new method for radioiodinating organic compounds via organoborane chemistry, J. Chem. Soc.,Chem. Commun. 1011 (1981).

    Google Scholar 

  21. G. W. Kabalka, K. A. R. Sastry, and K. Muralidhar, Synthesis of iodine-125 labelled aryl and vinyl iodides, J. Labelled Compds. Radiopharm. 19: 795 (1982).

    Article  CAS  Google Scholar 

  22. G. W. Kabalka, E. E. Gooch, and K. A. R. Sastry, Rapid and mild synthesis of radiodine labeled radiopharmaceuticals, J. Nucl. Med. 22: 908 (1981).

    PubMed  CAS  Google Scholar 

  23. G. W. Kabalka, “Radiohalogenation Method”, U. S. Patent No. 4,450, 149 (1984).

    Google Scholar 

  24. G. W. Kabalka and R. S. Varma, The synthesis of radiolabeled compounds via organometallic intermediates, Tetrahedron. 45: 6601 (1989).

    Article  CAS  Google Scholar 

  25. P. C. Srivastava and F. F. Knapp, [(E)-1-[123I]Iodo-lpenten-5-yl] triphenylphosphonium iodide: Convenient preparation of a potentially useful myocardial perfusion agent, J. Med. Chem. 27: 978 (1984).

    Article  PubMed  CAS  Google Scholar 

  26. M. M. Goodman, R. N. Waterhouse, G. W. Kabalka, and F. F. Knapp, Jr., Synthesis and biological evaluation of 3-C((E)-2 [125I)Iodoethenyl)-D-Allose: A new strategy for the preparation of in vivo stable radioiodinated carbohydrates, NucComp. 22: 62 (1990).

    Google Scholar 

  27. G. W. Kabalka, U. Sastry, K. A. R. Sastry, F. F. Knapp, and P. C. Srivastava, Synthesis of arylboronic acids via the reaction of borane complexes with arylmagnesium halides, J. Organomet. Chem. 259: 269 (1983).

    Article  CAS  Google Scholar 

  28. R. S. Varma and G. W. Kabalka, Synthesis and selected reactions of conjugated nitroalkenes, Org. Prep. Proced. Int. 19: 283 (1987).

    Article  Google Scholar 

  29. Srivastava, F. F. Knapp, Jr., A. P. Callahan, B. A. Owen, G. W. Kabalka, and K. A. Sastry, Myocardial imaging agents: Synthesis, characterization and evaluation of cis-(Z) and trans-(E)-18-bromo[82Br]5-tellura-l7-octadecenoic acid, J. Med. Chem. 28: 408 (1985).

    Article  PubMed  CAS  Google Scholar 

  30. S. A. Kunda, M. D. Smith, and G. W. Kabalka, Chlorination of organoboranes: Synthesis of (Z)-vinyl chlorides, Tetrahedron Lett. 26: 279 (1985).

    Article  CAS  Google Scholar 

  31. D. S. Wilbur, M. D. Hylarides, and A. R. Fritzberg, Reactions of organometallic compounds with astatine-211. Application to protein labeling, Radiochem. Acta. 47: 137 (1989).

    CAS  Google Scholar 

  32. H. C. Brown, M. M. Midland, and G. W. Kabalka, Organoboranes for synthesis. 5 Stoichiometrically controlled reaction of organoboranes with oxygen under mild conditions to achieve quantitative conversion to alcohols, Tetrahedron Lett. 42: 5523 (1980).

    Google Scholar 

  33. G. W. Kabalka, R. S. A. Kunda, Synthesis of organoborane 36: 853 (1985)

    CAS  Google Scholar 

  34. M. Lambrecht, M. Sajjad, J. S. Fowler, G. W. McCollum, and R. MacGregor, 150-labeled butanol via chemistry, Int. J. Appl. Radiat. Isot.

    Google Scholar 

  35. M. S. Berridge, E. H. Cassidy, and A. H. Terris. A routine, automated synthesis of oxygen-15-labeled butanol for positron tomography, J. Nucl. Med. 31: 1727 (1990).

    PubMed  CAS  Google Scholar 

  36. P. J. Kothari, R. D. Finn, G. W. Kabalka, M. M. Vora, T. E. Boothe, and A. M. Emran, Synthesis of nitrogen-13 labeled alkylamines via amination of organoboranes, Int. J. Rad. Appl. Instrum. [A] 37: 469 (1986).

    Article  CAS  Google Scholar 

  37. H. C. Brown, Organoborane-carbon monoxide reactions: Synthesis of carbon structures, Acc. Chem. Res. 2: 65 (1969).

    Article  CAS  Google Scholar 

  38. G. W. Kabalka, E. E. Gooch, C. J. Collins, and V. F. Raaen, A new method for isotopic labeling of organic compounds involving organoboranes, J. Chem. Soc., Chem. Commun. 607 (1979).

    Google Scholar 

  39. D. Y. Tang, A. Lipman, G.-J. Meyer, C.-N. Wan, and A. P. Wolf, Carbon-11 labeled octanal and benzaldehyde, J. Labelled Compd. Radiopharm. 16: 435 (1979).

    Article  CAS  Google Scholar 

  40. P. J. Kothari, R. D. Finn, M. M. Vora, T. E. Boothe, and A. M. Emran, 1–11C-Butanol: Synthesis and Development as a Radiopharmaceutical for Blood Flow Measurements, Int. J. Appl. Radiat. Isot. 36: 412 (1985).

    Article  PubMed  CAS  Google Scholar 

  41. P. J. Kothari, R. D. Finn, G. W. Kabalka, T. E. Boothe, A. Emran, and M. Mohammadi, Carbon-11 labeled dialkylketones: Synthesis of 9-[11C]-heptadecan-9-one, Int. J. Rad. Appl. Istrum. JA] 37: 471 (1986).

    Article  CAS  Google Scholar 

  42. G. W. Kabalka, Incorporation of carbon-13 and carbon-14 via organoborane technology Synth. Commun. 10: 93 (1980).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kabalka, G.W., Goodman, M.M. (1991). Synthesis of Radiopharmaceuticals Via Organoboranes. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0626-7_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0628-1

  • Online ISBN: 978-1-4899-0626-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics